top of page

The Proximal
Steerable Guide Catheter

A New Direction in Vascular Access.

Addressing the challenge

proximal image 2.png

Giving the tools that Surgeons Need and Want

Limitations of Current Tools

Standard catheters are rigid and pre-shaped, requiring multiple device exchanges.

A physician's “building a path” process is slower, potentially  increasing radiation exposure, and risk of complications. 

Tortuous paths utilizing limiting current tools dictate femoral access 

Increased Safety with Radial Access

Reduced Bleeding Complications

Over 100,000 patients die each year from a femoral access complication.

 

The radial approach is associated with a lower risk of bleeding complications compared to the femoral approach.

 

There is a 50% less chance of a transfusion required with a radial approach.

Picture22.png

Smaller Puncture Site

The radial artery is smaller in diameter than the femoral artery, which leads to a smaller puncture site and reduced risk of bleeding.

Easier Compression

The radial artery is more superficial and easier to apply compression to, further reducing the risk of bleeding.

 

Yet, a vast majority of neuro-interventionalists use the riskier femoral approach due to difficulty navigating the aortic arch from the wrist.

​

​

Why Radial is Favored

Lower access-site bleeding and vascular complications

​

Faster ambulation and earlier discharge

​

Greater patient comfort; useful when anticoagulated

or in obesity

When Femoral is Preferred

Need for large-bore access or complex device delivery

 

Unfavorable arm anatomy, severe tortuosity, or radial spasm/failure

Picture2.png

Use Across Specialties

•  Neurovascular: Diagnostic cerebral angiography and many endovascular treatments increasingly feasible trans-radially; due to tortuous pathways, femoral is still used a majority of the time.

 

•  Peripheral: Limb/visceral interventions can be

performed radially in suitable cases, though femoral often preferred for larger devices or complex anatomies.

​

•  Cardiovascular: Coronary angiography/PCI, selected structural/visceral work.

​​​​

PROXIMAL INC LOGO ONLY 6-20-25 REV 1.png

“This device is currently under development and has not been cleared  by the U.S. Food and Drug Administration. It is not available for commercial sale.”

bottom of page